Literature DB >> 18599247

Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.

Constantinos K Zacharis1, Paraskevas D Tzanavaras.   

Abstract

Bisphosphonates is a class of chemical compounds finding extensive medical applications against bone disorders including osteoporosis, Pagets' disease, etc. Non-N-containing members include etidronate, clodronate and tiludronate, while N-containing bisphosphonates include active pharmaceutical compounds such as pamidronate, neridronate, olpadronate, alendronate, ibandronate, risedronate and zoledronate. The present study covers 20 years of analytical research on this group of compounds, focusing on bioanalytical and pharmaceutical QC applications. A wide range of analytical techniques is presented and critically discussed including among others liquid and gas phase separations, electrophoretic, electroanalytical, automated and enzymatic approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599247     DOI: 10.1016/j.jpba.2008.05.028

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

Review 1.  Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants.

Authors:  Juan Pablo Cattalini; Aldo R Boccaccini; Silvia Lucangioli; Viviana Mouriño
Journal:  Tissue Eng Part B Rev       Date:  2012-05-14       Impact factor: 6.389

2.  Development of local strontium ranelate delivery systems and long term in vitro drug release studies in osteogenic medium.

Authors:  Dagnija Loca; Anastasija Smirnova; Janis Locs; Arita Dubnika; Jana Vecstaudza; Liga Stipniece; Elina Makarova; Maija Dambrova
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

3.  Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation.

Authors:  Anca-Roxana Petrovici; Mihaela Silion; Natalia Simionescu; Rami Kallala; Mariana Pinteala; Stelian S Maier
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir.

Authors:  Yu-Tian Liu; Wei Liu; Gang-Yan Zhu; Fu-Liang Wang; Qian Chen
Journal:  Mol Med Rep       Date:  2018-03-19       Impact factor: 2.952

5.  Strong binding and fluorescence sensing of bisphosphonates by guanidinium-modified calix[5]arene.

Authors:  Jie Gao; Zhe Zheng; Lin Shi; Si-Qi Wu; Hongwei Sun; Dong-Sheng Guo
Journal:  Beilstein J Org Chem       Date:  2018-07-19       Impact factor: 2.883

6.  The Effects of Various Food Products on Bisphosphonate's Availability.

Authors:  Monika Zielińska; Grzegorz Garbacz; Jaroslaw Sczodrok; Adam Voelkel
Journal:  Pharmaceutics       Date:  2022-03-27       Impact factor: 6.525

7.  A novel micro-extraction strategy for extraction of bisphosphonates from biological fluids using zirconia nanoparticles coupled with spectrofluorimetry and high performance liquid chromatography.

Authors:  Nadereh Rahbar; Ladan Nazernezhad; Maryam Asadinezhad; Zahra Ramezani; Maryam Kouchak
Journal:  J Food Drug Anal       Date:  2018-04-05       Impact factor: 6.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.